Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Nature Communications|June 8, 2022
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individualsNina G Bozhanova, Andrew I Flyak, Benjamin P Brown, et al.Structure (London, England : 1993)|August 2, 2016
Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing AntibodiesThaddeus M Davenport, Jason Gorman, M Gordon Joyce, et al.Plos One|July 4, 2014
Transplanting supersites of HIV-1 vulnerabilityTongqing Zhou, Jiang Zhu, Yongping Yang, et al.Plos One|June 15, 2016
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8Cinque Soto, Gilad Ofek, M Gordon Joyce, et al.Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failureZhaochun Chen, Giacomo Diaz, Teresa Pollicino, et al.The Journal of Clinical Investigation|June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.Mabs|December 30, 2021
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage librariesTom Z Yuan, Pankaj Garg, Linya Wang, et al.Cell|April 14, 2015
Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 InfectionXueling Wu, Zhenhai Zhang, Chaim A Schramm, et al.Nature Structural & Molecular Biology|August 2, 2016
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSVM Gordon Joyce, Baoshan Zhang, Li Ou, et al.Science (New York, N.Y.)|November 2, 2013
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virusJason S McLellan, Man Chen, M Gordon Joyce, et al.Pageof 5